Related Experiment Video
Updated: Jul 21, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Phosphate Toxicity and Vascular Calcification in Chronic Kidney Disease: A Closer Look Utilizing Transmission
Ying Yang1,2, Ke Yang2,3, Yuxin Xiong1,2
1Department of Endocrinology, the Affiliated Hospital of Yunnan University and the Second People's Hospital of Yunnan Province, Kunming, Yunnan, 650021, China.
Insights
Hyperphosphatemia in chronic kidney disease (CKD) and end-stage renal disease (ESRD) is linked to severe complications. This review explores phosphate toxicity, FGF-23/Klotho axis, and vascular calcification in CKD.
Area of Science:
- Nephrology
- Cardiovascular Science
- Metabolic Disorders
Background:
- Hyperphosphatemia is a significant complication in chronic kidney disease (CKD) and end-stage renal disease (ESRD), independently associated with vascular calcification, cardiovascular disease, bone-mineral disease, and mortality.
- The fibroblast growth factor-23 (FGF-23)/Klotho axis is crucial for phosphate homeostasis, with diminished renal Klotho production contributing to elevated phosphate levels in CKD.
- Associated complications include calciphylaxis, renal tubulointerstitial disease, renal osteodystrophy, and uremic cardiomyopathy.
Purpose of the Study:
- To review the multifaceted roles of phosphate homeostasis and toxicity in CKD and ESRD.
- To examine the contribution of the FGF-23/Klotho axis to hyperphosphatemia and its consequences.
- To explore the ultrastructural remodeling of the thoracic aorta and its relation to vascular calcification, incorporating insights from animal models.
Main Methods:
- Review of existing literature on hyperphosphatemia, FGF-23, Klotho, and vascular calcification in CKD/ESRD.
- Incorporation of ultrastructural remodeling data of the thoracic aorta.
- Utilization of data from nine-week-old male heterozygous (mRen2) 27 (Ren2) rat models and Zucker obese (fa/fa) rat models.
Main Results:
- Hyperphosphatemia is a key driver of vascular calcification, cardiovascular disease, and mortality in CKD/ESRD.
- Dysregulation of the FGF-23/Klotho axis contributes to phosphate retention and associated pathologies.
- Animal models demonstrate aortic remodeling linked to vascular calcification and provide insights into nephrolith formation.
Conclusions:
- Phosphate homeostasis, toxicity, and the FGF-23/Klotho axis are central to understanding CKD/ESRD progression and complications.
- Vascular calcification, driven by hyperphosphatemia, involves complex cellular and molecular mechanisms including oxidative stress and inflammation.
- Further research into these pathways is essential for developing targeted therapies for CKD/ESRD patients.
Abstract:
Hyperphosphatemia is independently linked with vascular calcification, cardiovascular disease, bone-mineral disease, progression of renal insufficiency, and all-cause mortality in chronic kidney disease (CKD) and end-stage renal disease (ESRD). The emerging importance of fibroblast growth factor-23 (FGF-23) and its co-factor Klotho play very important roles as phosphaturic hormones; however, phosphate levels rise due to a loss of renal Klotho production and the phosphaturic effects of the FGF-23/Klotho axis. Hyperphosphatemia is also associated with calciphylaxis, acceleration of renal tubulointerstitial disease, renal osteodystrophy, and uremic cardiomyopathy. This review incorporates ultrastructural remodeling of the thoracic aorta to provide a different perspective on vascular calcification. Nine-week-old male heterozygous (mRen2) 27 (Ren2) rat models of hypertension, insulin resistance, vascular oxidative stress and albuminuria are utilized to demonstrate aortic remodeling associated with vascular calcification. Nine-week-old male Zucker obese (fa/fa) rat models are utilized to better understand nephrolith formation. Phosphate homeostasis, toxicity, multiple metabolic and uremic toxicities, renal osteodystrophy, and vascular calcification are also discussed. Additionally, the role of the endothelium, vascular smooth muscle cells, inflammatory monocytes/macrophages and mast cells, pericytes, oxidative stress, hydrogen sulfide, and extraosseous calcification in the kidney are discussed as they relate to CKD, ESRD and calciphylaxis.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Chronic Kidney Disease IV: Nursing Management

